Free shipping on all orders over $ 500

PDE Phosphodiesterase

Cat.No.  Name Information
M2030 Apremilast Apremilast is a novel, orally available small molecule inhibitor of PDE4 with IC50 of 74 nM.
M6804 IBMX IBMX is a pDE inhibitor (non-selective) with IC50 values of 6.5±1.2, 26.3±3.9 and 31.7±5.3 μM for PDE3, 4 and 5 respectively.
M3700 PF8380 Pf-8380 is a potent autotaxin inhibitor with IC50 of 2.8 nM and 101 nM in in vitro enzyme assay and human whole blood cell assay, respectively.
M3588 Aminophylline Aminophylline is a competitive nonselective phosphodiesterase inhibitor with an IC50 of 0.12 mM and also a nonselective adenosine receptor antagonist.
M3587 Dyphylline Dyphylline is a xanthine derivative with bronchodilator and vasodilator effects.
M3566 Vardenafil hydrochloride Trihydrate Vardenafil hydrochloride Trihydrate is a new type PDE inhibitor with IC50 of 0.7 and 180 nM for PDE5 and PDE1, respectively.
M3473 Tadalafil Tadalafil is a PDE-5 inhibitor with IC50 of 1.8 nM.
M3447 PF-2545920 PF-2545920 is a potent and selective PDE10A inhibitor with IC50 of 0.37 nM, with >1000-fold selectivity over the PDE.
M3437 Cilomilast Cilomilast is a potent PDE4 inhibitor with IC50 of about 110 nM, has anti-inflammatory activity and low central nervous system activity.
M3434 Pimobendan Pimobendan is a selective inhibitor of PDE3 with IC50 of 0.32 μM.
M3394 Deltarasin Deltarasin is a novel small molecule which inhibits the KRAS-PDEδ interaction and thus impairing oncogenic KRAS signalling.
M3375 S-(+)-Rolipram S-(+)-Rolipram inhibits human monocyte cyclic AMP-specific PDE4 with IC50 of 0.75 μM, has anti-inflammatory and anti-depressant activity in the central nervous system, less potent than its R enantiomer.
M3337 Milrinone Milrinone is a potent and selective phosphodiesterase 3 inhibitor with an IC50 of 0.42 μM for the inhibition of FIII PDE.
M3259 Irsogladine Irsogladine is an anti-gastric ulcer agent that facilitates gap-junctional intercellular communication through M1 muscarininc acetylcholine receptor binding.
M2923 Pentoxifylline Pentoxifylline is a competitive nonselective phosphodiesterase inhibitor which raises intracellular cAMP, activates PKA, inhibits TNF and leukotriene synthesis, and reduces inflammation and innate immunity.
M2764 Ibudilast Ibudilast is a potent PDE4 inhibitor for PDE4A with IC50 of 54 nM.
M2702 Flavoxate hydrochloride Flavoxate is a muscarinic AChR antagonist with IC50 of 12.2 μM.
M2651 Doxofylline Doxofylline is a xanthine derivative and a phosphodiesterase (PDE) inhibitor that can be used in asthma-related studies.
M2410 Avanafil Avanafil is a highly selective PDE5 inhibitor with IC50 of 5.2 nM, >121-fold selectivity over other PDEs.
M2395 Anagrelide hydrochloride Anagrelide HCl is a primary thrombocytopenia compound. It has anti-cyclic adenylate phosphodiesterase activity and inhibits platelet aggregation in both humans and animals. Anagrelide works by inhibiting megakaryocytes from maturing into platelets.
M2337 AN2728 AN2728 is a topical anti-inflammatory product candidate for the treatment of psoriasis and atopic dermatitis.
M2286 Sildenafil citrate Sildenafil citrate is an agent used to treat erectile dysfunction and pulmonary arterial hypertension (PAH).




Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.